Adverse events46

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 46

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anorexia	Metabolism and nutrition disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	9	27	14
other	Chills	General disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	5	27	7
other	Diarrhea	Gastrointestinal disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	4	27	5
other	Fatigue	General disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	7	27	7
other	Fever	General disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	10	27	16
other	Flu-like symptoms	Infections and infestations	Prevnar, T Cells, Lenalidomide, MAGE A-3	2	27	3
other	Generalized muscle weakness	Musculoskeletal and connective tissue disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	2	27	2
other	Headache	Nervous system disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	8	27	10
other	Increased eosinophil	Blood and lymphatic system disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	2	27	3
other	Induration	Skin and subcutaneous tissue disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	3	27	5
other	Induration - thigh	Skin and subcutaneous tissue disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	2	27	2
other	Induration at injection site	Skin and subcutaneous tissue disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	7	27	14
other	Induration/Swelling	Skin and subcutaneous tissue disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	4	27	7
other	Injection site reaction	General disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	8	27	36
other	Loss of energy	Nervous system disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	8	27	13
other	Muscle aches	Musculoskeletal and connective tissue disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	11	27	17
other	Nausea	Gastrointestinal disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	5	27	6
other	Neutrophil count decreased	Investigations	Prevnar, T Cells, Lenalidomide, MAGE A-3	2	27	2
other	Pain at injection site	Gastrointestinal disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	16	27	40
other	Pruritis	Skin and subcutaneous tissue disorders	Prevnar, T Cells, Lenalidomide, MAGE A-3	2	27	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01245673/events

API reference For AI assistants

Adverse events46

Sources 3

Read this list from software.